[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359730-105":59,"doc-detail-359730-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multi-omics-profiling-uncovers-predictive-factors-for-tumor-infiltrating-lymphocyte-therapy-in-ovarian-cancer","Multi-Omics Profiling Uncovers Predictive Factors for Tumor-Infiltrating Lymphocyte Therapy in Ovarian Cancer","","Ovarian cancer remains a difficult malignancy with poor outcomes, while tumor-infiltrating lymphocyte therapy shows uneven clinical results. This study applies multi-omics profiling to determine predictors of successful TIL isolation and expansion in ovarian cancer. Tumor data from 10 patients integrates whole-exome sequencing, bulk RNA sequencing, and single-cell RNA sequencing to compare TIL+ versus TIL- products. Findings identify immune infiltration patterns, metabolic activity, distinct myeloid and fibroblast subpopulations, and cell-to-cell communication signals linked to TIL manufacturing success.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-profiling-uncovers-predictive-factors-for-tumor-infiltrating-lymphocyte-therapy-in-ovarian-cancer/359730/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-profiling-uncovers-predictive-factors-for-tumor-infiltrating-lymphocyte-therapy-in-ovarian-cancer/359730.png","ImageObject",300,407,{"name":92,"@type":93},"Riley West","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of this study?","Question",{"text":112,"@type":113},"To identify factors that predict successful tumor-infiltrating lymphocyte (TIL) isolation and expansion in ovarian cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was multi-omics profiling performed in this research?",{"text":117,"@type":113},"Tumor samples from 10 patients were analyzed using whole-exome sequencing, bulk RNA sequencing, and single-cell RNA sequencing.",{"name":119,"@type":110,"acceptedAnswer":120},"What distinguishes TIL+ tumors from TIL- tumors according to the results?",{"text":121,"@type":113},"TIL+ tumors show higher immune cell infiltration, especially CD8+ effector and effector memory T cells, along with enhanced metabolic activity and distinct myeloid and fibroblast subpopulations linked to TIL outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359730,1790761407,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Journal of Clinical Laboratory Analysis   \n RESEARCH ARTICLE  OPEN ACCESS   \nMulti-Omics Profiling Uncovers Predictive Factors for  \nTumor-Infiltrating Lymphocyte Therapy in Ovarian Cancer  \nXiuzhen Wang1  | Rui Hou2  | Jinguo Chen3  | Bo He4  | Peiwen Liu4  | Genhai Zhu1  | Lan Hong1  | Wenjun Zhu5   \n1Department of Gynaecology, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital), Haikou, China | 2Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, the First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Shenzhen, China | 3Center for Human Immunology, Autoimmunity and Inflammation (CHI), National Institutes of Health, Bethesda, USA | 4Harry Perkins Institute of Medical Research, QEII Medical Centre, and Centre for Medical Research, The University of Western Australia, Perth, Western Australia, Australia | 5SolidCure (Taizhou) BioMed Co. Ltd, Taizhou, Jiangsu, China  \nCorrespondence: Lan Hong ([honglan625402542@163.com](honglan625402542@163.com)) | Wenjun Zhu ([nih44011488@yahoo.com](nih44011488@yahoo.com))  \nReceived: 30 October 2025 | Revised: 1 February 2026 | Accepted: 26 February 2026  \nABSTRACT  \nBackground: Ovarian cancer (OC) remains a challenging malignancy with a poor prognosis, particularly in advanced stages. Tumor-infiltrating lymphocyte (TIL) therapy shows promise but has yielded inconsistent results in OC patients. This study aimed to identify factors predicting successful TIL isolation and expansion in OC.  \nMethods: We performed multi-omics profiling on tumor samples from 10 OC patients, including whole-exome sequencing, bulk RNA sequencing, and single-cell RNA sequencing.  \nResults: Genomic analysis revealed heterogeneity in tumor mutation burden, copy number variations, and homologous recombination deficiency status across patients. Single-cell profiling uncovered distinct cellular compositions in tumors, yielding successful TIL products (TIL+) vs. those that did not (TIL-). TIL+ tumors exhibited higher immune cell infiltration, particularly CD8+ effector and effector memory T cells. Metabolic profiling revealed enhanced activity in critical T cell subtypes within TIL+ tumors. Analysis of myeloid cells and fibroblasts identified subpopulations uniquely associated with TIL+ or TIL-samples. Cellto-cell communication network analysis highlighted potential prognostic markers and interactions influencing TIL isolation outcomes.  \nConclusion: Our findings provide insights into factors affecting TIL therapy efficacy in OC and suggest potential strategies for optimizing patient selection and TIL manufacturing protocols.  \n1 | Introduction  \nDue to a lack of symptoms, ovarian cancer (OC) often remains undiagnosed until it has advanced [1] . In the context of the United States, the survival rate over a span of five years for cases of ovarian cancer is documented to be 46. 2%[2] . This is predominantly attributed to the diagnosis of more than 70% of ovarian cancer cases at an advanced stage, specifically stages III and IV [3] . Despite recent progress with poly-[adenosine  \ndiphosphate (ADP)-ribose] polymerase inhibitors (PARPi) extending progression-free survival, the overall survival (OS) of patients with high-grade serous ovarian carcinoma (HGSOC), the most common (~70%) histological subtype, remains poor [4] . New therapeutic options are urgently needed to improve outcomes for these patients [5] .  \nAdoptive tumor-infiltrating lymphocyte (TIL) therapy, which has been at the forefront of new clinical trials for many solid  \n\n| The first two authors contributed equally to this article. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.\u003Cb","cbCairUFJvSpWLQb","https://ap.wps.com/l/cbCairUFJvSpWLQb","pdf",6816093,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Disease burden and diagnosis\n## Rationale for TIL therapy\n## Clinical challenges and research direction","[{\"question\":\"What was the main goal of this study?\",\"answer\":\"To identify factors that predict successful tumor-infiltrating lymphocyte (TIL) isolation and expansion in ovarian cancer patients.\"},{\"question\":\"How was multi-omics profiling performed in this research?\",\"answer\":\"Tumor samples from 10 patients were analyzed using whole-exome sequencing, bulk RNA sequencing, and single-cell RNA sequencing.\"},{\"question\":\"What distinguishes TIL+ tumors from TIL- tumors according to the results?\",\"answer\":\"TIL+ tumors show higher immune cell infiltration, especially CD8+ effector and effector memory T cells, along with enhanced metabolic activity and distinct myeloid and fibroblast subpopulations linked to TIL outcomes.\"}]","Multi-Omics Profiling Uncovers Predictive Factors for Tumor-Infiltrating Lymphocyte Therapy in Ovarian Cancer | PDF",1790137663,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1871cedd180b3cc35d9c3efef73dfbc.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a1dc1176ee1614919a6dc0483faf8c6.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8593c77bdbf7a99db123ebcc33f26f62.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a62ec5511cb4943c81b499c3db73635.webp",980,1287]